In a 28-year-old with a third depressive episode in four years presenting with low energy, worthlessness, poor concentration, sleep disturbance, social withdrawal, and crying episodes but no suicidal ideation, would solution-focused brief psychotherapy be effective?

Solution-Focused Brief Therapy for Recurrent Major Depression

Solution-focused brief therapy (SFBT) is not the optimal first-line psychotherapy for this patient with recurrent major depressive disorder. The American College of Physicians guidelines specifically recommend cognitive behavioral therapy (CBT) or second-generation antidepressants as first-line treatments for major depression, with no mention of SFBT as an evidence-based option 1.

Why CBT or Antidepressants Are Preferred

The 2016 ACP guidelines, based on systematic review of high-quality evidence, establish that CBT and second-generation antidepressants have equivalent efficacy for moderate to severe major depressive disorder, with similar response rates (44% vs. 46%) and remission rates (41% vs. 48%) after 8-16 weeks 2. Critically for this patient with recurrent episodes, CBT demonstrates lower relapse rates (2-39%) compared to antidepressants alone (11-59%) 2, making it particularly valuable for preventing the fourth episode.

The Evidence Gap for SFBT in Major Depression

While recent research shows SFBT can reduce depressive symptoms 3, 4, 5, these studies have critical limitations:

• The 2024 meta-analysis found smaller effects in clinical samples (g=0.78) versus non-clinical samples (g=1.50) 3, suggesting SFBT works better for subclinical distress than diagnosed major depression
• Studies comparing SFBT to treatment-as-usual showed modest effects (g=0.58) 3
• Most SFBT research involves case reports 6, 7 or populations other than recurrent major depression 8
• No guideline-level evidence supports SFBT as first-line treatment for major depressive disorder

Recurrent Depression Requires Proven Interventions

This patient's third episode in four years signals a chronic, relapsing condition requiring evidence-based maintenance strategies. The ACP guidelines emphasize that treatment phases include acute (6-12 weeks), continuation (4-9 months), and maintenance (≥1 year) phases 1. CBT's demonstrated superiority in preventing relapse makes it the logical choice over an intervention lacking robust evidence in recurrent major depression.

Clinical Algorithm

For this 28-year-old with recurrent major depression:

1. Offer CBT as first-line psychotherapy (8-16 sessions initially) 2, 1
2. Alternatively, offer a second-generation antidepressant if CBT is inaccessible or patient preference dictates
3. Consider combination therapy (CBT + antidepressant) if response is inadequate, though evidence shows this may not significantly improve outcomes over monotherapy 2
4. Plan for continuation treatment (4-9 months) and discuss maintenance strategies given recurrent pattern

Common Pitfall

Do not assume all brief psychotherapies are equivalent. While SFBT may help with general psychological distress or subclinical symptoms 9, the evidence hierarchy clearly favors CBT for diagnosed major depressive disorder. Using an intervention with weaker evidence risks inadequate treatment of a serious, recurrent condition that significantly impairs functioning and quality of life.

The strength-based, goal-directed nature of SFBT may appeal to some patients, but clinical decision-making must prioritize interventions with established efficacy for the specific diagnosis and clinical context—in this case, recurrent major depression requiring relapse prevention.